SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gilead Science (GILD) Followers -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (556)9/15/1998 11:05:00 PM
From: John Metcalf  Read Replies (1) | Respond to of 961
 
Point well taken, Rick. Suppose we jumped way out on a limb, and pretended that Gilead's value had something to do with preventing or treating influenza. Is there any possibility at all that Aviron's setback has increased speculation that GILD will be first to market?

naah. Forget I said it. Summer's over, and now biotechs go up. Noted experts say so -:)